valsartan has been researched along with Goldblatt Syndrome in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 10 (66.67) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crane, JA; Jordan, KL; Lerman, A; Lerman, LO; Li, ZL; Pawar, AS; Textor, SC; Zhang, X | 1 |
| Chen, X; Dong, J; Jiang, L; Jiang, W; So, Y; Xin, H | 1 |
| Delić-Brkljacić, D; Gaćina, P; Galesić, K; Ivanac, G; Manola, S; Pintarić, H; Radeljić, V; Stambuk, K | 1 |
| Chen, JW; Fang, J; Gao, J; Huang, HQ; Liu, PQ; Tang, FT; Wang, P; Xu, SW; Zhou, SG | 1 |
| Lu, JY; Qin, XT; Sheng, HZ; Yu, XH; Zhu, JH | 1 |
| Alba, F; Banegas, I; de Gasparo, M; Hermoso, F; Prieto, I; Ramírez, M; Segarra, AB; Vargas, F | 1 |
| Alba, F; Banegas, I; Gasparo, Md; Hermoso, F; Prieto, I; Ramírez, M; Segarra, AB; Vargas, F | 1 |
| Bellido, D; Nieto, J; Oteros, R; Rivera, F; Sánchez de la Nieta, MD; Vozmediano, C; Zarca, MA | 1 |
| Imamoto, S; Kuno, M; Mochizuki, S; Nagai, M; Okada, T; Seki, S; Taniguchi, I; Taniguchi, M | 1 |
| Chen, S; Huang, H; Li, R; Liu, P; Tang, F; Wang, P; Zhang, H | 1 |
| Balaev, VV; Drozdova, GA; Frolov, VA; Mustiatsa, VF; Rieger, P | 1 |
| Balaev, VV; Drozdova, GA; Frolov, VA; Mustiatsa, VF | 1 |
| Hartner, A; Hilgers, KF; Mann, JF; Porst, M; Veelken, R | 1 |
| Alba, F; de Gasparo, M; Hermoso, F; Martínez, JM; Prieto, I; Ramírez, M; Ramírez, MJ; Vargas, F | 1 |
| Becherer, A; Dudczak, R; Karanikas, G; Kletter, K; Wiesner, K | 1 |
2 trial(s) available for valsartan and Goldblatt Syndrome
| Article | Year |
|---|---|
Influence of ATII blockers and calcium channel blockers on renal vascular resistance in patients with essential hypertension.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Calcium Channel Blockers; Croatia; Female; Humans; Hypertension; Hypertension, Renovascular; Kidney; Male; Middle Aged; Regression Analysis; Tetrazoles; Ultrasonography, Doppler, Duplex; Valine; Valsartan; Vascular Resistance | 2009 |
ACE inhibition is superior to angiotensin receptor blockade for renography in renal artery stenosis.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Humans; Hypertension, Renovascular; Male; Middle Aged; Radioisotope Renography; Radiopharmaceuticals; Renal Artery Obstruction; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Mertiatide; Tetrazoles; Valine; Valsartan | 2002 |
13 other study(ies) available for valsartan and Goldblatt Syndrome
| Article | Year |
|---|---|
Valsartan regulates myocardial autophagy and mitochondrial turnover in experimental hypertension.
Topics: Animals; Antihypertensive Agents; Autophagy; Blood Pressure; Heart; Hypertension, Renovascular; Mitochondria; Mitochondrial Turnover; Myocardium; Swine; Tetrazoles; Valine; Valsartan; Ventricular Remodeling | 2014 |
[Intermedin (IMD) gene expression in hypertrophic cardiac myocyte of renal vascular hypertension rats and the intervention of Valsartan, Amlodipine and Enalapril in the expression].
Topics: Adrenomedullin; Amlodipine; Animals; Antihypertensive Agents; Cardiomegaly; Enalapril; Hypertension, Renovascular; Male; Myocardium; Neuropeptides; Random Allocation; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tetrazoles; Valine; Valsartan | 2009 |
Tanshinone II-A attenuates cardiac fibrosis and modulates collagen metabolism in rats with renovascular hypertension.
Topics: Abietanes; Animals; Blood Pressure; Cardiovascular Agents; Collagen; Drugs, Chinese Herbal; Fibrosis; Gene Expression; Heart; Hypertension, Renovascular; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocardium; Phytotherapy; Rats; Rats, Sprague-Dawley; RNA, Messenger; Salvia miltiorrhiza; Tetrazoles; Tissue Inhibitor of Metalloproteinase-1; Valine; Valsartan | 2010 |
[Role of valsartan on myocardial Calpain I, calcineurin and Ca/calmodulin-dependent protein kinase IIδ expression of renovascular hypertensive rats].
Topics: Animals; Calcineurin; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calpain; Hypertension, Renovascular; Male; Myocardium; Rats; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Tetrazoles; Valine; Valsartan | 2012 |
Aminopeptidase activity in renovascular hypertension.
Topics: Aminopeptidases; Angiotensin II; Animals; Antihypertensive Agents; Aorta; Down-Regulation; Heart Atria; Heart Ventricles; Hypertension; Hypertension, Renovascular; Lung; Male; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Tetrazoles; Valine; Valsartan | 2003 |
Angiotensinase activities in the kidney of renovascular hypertensive rats.
Topics: Adrenal Cortex; Adrenal Medulla; Aminopeptidases; Angiotensin II Type 1 Receptor Blockers; Animals; CD13 Antigens; Cell Membrane; Endopeptidases; Glutamyl Aminopeptidase; Hypertension, Renovascular; Kidney; Rats; Rats, Wistar; Tetrazoles; Valine; Valsartan | 2003 |
[Acute renal failure and hypertension].
Topics: Acute Kidney Injury; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Humans; Hypertension, Renovascular; Male; Middle Aged; Tetrazoles; Valine; Valsartan | 2005 |
Combined treatment with valsartan and spironolactone prevents cardiovascular remodeling in renovascular hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Cardiovascular Physiological Phenomena; Hypertension, Renovascular; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Rats; Rats, Wistar; Spironolactone; Tetrazoles; Valine; Valsartan; Ventricular Remodeling | 2006 |
Contribution of different Nox homologues to cardiac remodeling in two-kidney two-clip renovascular hypertensive rats: effect of valsartan.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Cardiomegaly; Disease Models, Animal; Fibrosis; Heart Ventricles; Hypertension, Renovascular; Ligation; Male; Malondialdehyde; Membrane Glycoproteins; NADH, NADPH Oxidoreductases; NADPH Oxidase 1; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Rats; Rats, Sprague-Dawley; Renal Artery; Superoxides; Tetrazoles; Valine; Valsartan; Ventricular Function, Left; Ventricular Remodeling | 2007 |
[Myocardial hypertrophy in rabbits with vasorenal arterial hypertension during pharmacological blockade of formation of angiotensin II and its interaction with specific receptors].
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomegaly; Hypertension, Renovascular; Hypertrophy, Left Ventricular; Male; Myocardium; Rabbits; Receptors, Angiotensin; Tetrazoles; Valine; Valsartan | 1999 |
[Morphofunctional characteristics of myocardial hypertrophy in rabbits with vasorenal arterial hypertension during pharmacological blockade of angiotensin II].
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Heart Ventricles; Hypertension, Renovascular; Hypertrophy, Left Ventricular; Male; Organ Size; Rabbits; Tetrazoles; Valine; Valsartan | 1999 |
Angiotensin II type 1 receptor blockade prevents lethal malignant hypertension: relation to kidney inflammation.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Chemokine CCL2; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertension, Malignant; Hypertension, Renovascular; Immunohistochemistry; Kidney; Macrophages; Male; Nephritis; Organ Size; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Survival Rate; Tetrazoles; Valine; Valsartan | 2001 |
Effect of valsartan on angiotensin II- and vasopressin-degrading activities in the kidney of normotensive and hypertensive rats.
Topics: Aminopeptidases; Angiotensin II; Animals; Antihypertensive Agents; Arginine Vasopressin; Blood Pressure; Cystinyl Aminopeptidase; Drinking; Glutamyl Aminopeptidase; Hypertension, Renovascular; Kidney; Male; Placebos; Rats; Rats, Wistar; Tetrazoles; Valine; Valsartan | 2001 |